Full Text
PHP104 Potential Implications of National Disease Registries and Centers of Excellence for Orphan Diseases for Pharmaceutical Manufacturers Developing Orphan Drugs

Abstract

Authors

D. Dobrovolny A. Patel R. Dalsania M. Paas

Back to Volume 15, Issue 4
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×